8.9
Mémoire immunitaire et autres aspects de CRISPR
Le système CRISPR-Cas constitue un mécanisme de défense bactérien contre les éléments génétiques envahissants tels que les virus et les plasmides, et…
Le système CRISPR-Cas protège les bactéries des éléments génétiques étrangers.
En laboratoire, le système est programmé à l’aide de Cas-9 pour modifier les gènes des plantes, des animaux et des humains.
Cas9, une endonucléase de Streptococcus pyogenes, est délivré dans les cellules avec un ARN-ARNsg guide synthétique.
L’ARNsg guide Cas9 vers la séquence du motif adjacent Protospacer, ce qui lui permet de se lier et de couper l’ADN au site cible.
Pour l’insertion du gène, Cas9, guidé par un ARNsg, divise le site, permettant une recombinaison homologue pour insérer le nouveau gène.
Pour la délétion du gène, deux ARNsg ordonnent à Cas9 de couper les deux extrémités de la région cible.
Le gène est excisé et le système de réparation relie les extrémités coupées.
CRISPR-Cas9 a été conçu pour inactiver le VIH en excisant son ADN des cellules infectées. Les systèmes modifiés comme Csy4 ciblent l’ARN libre du VIH, bien que ces méthodes soient encore expérimentales.
En plus de cibler un seul locus, CRISPR-Cas9 peut modifier plusieurs gènes simultanément, par exemple en supprimant plusieurs copies rétrovirales.
View the full transcript and gain access to JoVE Core videos
Q1: How does Cas9 identify and cut DNA at the target site?
Cas9, an endonuclease from Streptococcus pyogenes, uses a synthetic guide RNA (sgRNA) to locate specific DNA sequences. The sgRNA directs Cas9 to the Protospacer Adjacent Motif (PAM) sequence, typically 5'-NGG-3', allowing Cas9 to bind and introduce a double-stranded break at the precise target location.
Q2: What is the difference between gene insertion and gene deletion using CRISPR-Cas9?
Gene insertion uses one sgRNA to guide Cas9 to cleave a site, then homologous recombination inserts new genetic material. Gene deletion employs two sgRNAs directing Cas9 to cut both ends of a target region, excising the DNA fragment, which the cell's repair system then rejoins through non-homologous end joining.
Q3: How can CRISPR-Cas9 be used to treat HIV infections?
CRISPR-Cas9 has been designed to inactivate HIV by excising integrated viral DNA from infected cells. Additionally, engineered systems like Csy4 target free HIV RNA to degrade it, though these antiviral strategies remain experimental and represent emerging therapeutic approaches for combating viral infections.
Q4: What is the original function of the CRISPR-Cas system in bacteria?
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids. Originally discovered in prokaryotes, the antiviral system of bacteria and archaea has been repurposed as a powerful genome-editing tool for laboratory applications across diverse organisms.
Q5: Can CRISPR-Cas9 edit multiple genes simultaneously?
Yes, CRISPR-Cas9 enables multiplexed genome editing, allowing simultaneous modification of multiple genes in a single organism. This capability is particularly advantageous in complex genetic studies and therapeutic applications, such as removing multiple retroviral copies from infected cells in one editing event.
Q6: What organisms can be edited using CRISPR-Cas9 technology?
CRISPR-Cas9 has been reprogrammed to modify the genomes of diverse organisms, including plants, animals, and humans. This versatility makes it a revolutionary tool for genetic engineering across a wide range of biological systems and research applications in both basic and applied science.
Q7: How does the synthetic guide RNA direct Cas9 to the correct DNA location?
The synthetic single guide RNA (sgRNA) contains a complementary sequence that guides Cas9 to a specific genomic locus adjacent to the Protospacer Adjacent Motif (PAM). This precise targeting ensures Cas9 binds and cuts only at the intended DNA location, enabling accurate and efficient genome editing with minimal off-target effects.